The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Li Watsek is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/31/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/31/2024 | ARVN | Buy Now | Arvinas | $27.30 | — | — | Reiterates | → Overweight | Get Alert |
| 05/29/2024 | ALXO | Buy Now | ALX Oncology Holdings | $5.56 | — | — | Reiterates | → Overweight | Get Alert |
| 05/15/2024 | ASND | Buy Now | Ascendis Pharma | $136.85 | 26.42% | → $173 | Reiterates | Overweight → Overweight | Get Alert |
| 05/15/2024 | CRIS | Buy Now | Curis | $5.60 | — | — | Reiterates | → Overweight | Get Alert |
| 05/03/2024 | ASND | Buy Now | Ascendis Pharma | $136.85 | 26.42% | → $173 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2024 | ASND | Buy Now | Ascendis Pharma | $136.85 | 26.42% | → $173 | Reiterates | Overweight → Overweight | Get Alert |
| 04/12/2024 | ALXO | Buy Now | ALX Oncology Holdings | $5.56 | — | — | Reiterates | → Overweight | Get Alert |
| 04/09/2024 | VINC | Buy Now | Vincerx Pharma | $0.63 | — | — | Reiterates | → Overweight | Get Alert |
| 04/01/2024 | ASND | Buy Now | Ascendis Pharma | $136.85 | 26.42% | → $173 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | VINC | Buy Now | Vincerx Pharma | $0.63 | — | — | Reiterates | → Overweight | Get Alert |
| 04/01/2024 | CRVS | Buy Now | Corvus Pharma | $2.65 | — | — | Reiterates | → Overweight | Get Alert |
| 04/01/2024 | AFMD | Buy Now | Affimed | $5.29 | — | — | Reiterates | → Overweight | Get Alert |
| 02/06/2024 | ASND | Buy Now | Ascendis Pharma | $136.85 | 26.42% | $152 → $173 | Maintains | Overweight | Get Alert |
| 12/20/2023 | ASND | Buy Now | Ascendis Pharma | $136.85 | 11.07% | → $152 | Reiterates | Overweight → Overweight | Get Alert |
| 11/22/2023 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.20 | 150% | → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 11/08/2023 | RCUS | Buy Now | Arcus Biosciences | $15.88 | 126.7% | $46 → $36 | Maintains | Overweight | Get Alert |
| 11/08/2023 | BCYC | Buy Now | Bicycle Therapeutics | $24.76 | 162.52% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 10/04/2023 | ALXO | Buy Now | ALX Oncology Holdings | $5.56 | 313.67% | $18 → $23 | Maintains | Overweight | Get Alert |
| 09/25/2023 | AFMD | Buy Now | Affimed | $5.29 | 32.33% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/15/2023 | ASND | Buy Now | Ascendis Pharma | $136.85 | 11.07% | → $152 | Reiterates | Overweight → Overweight | Get Alert |
| 09/12/2023 | BCYC | Buy Now | Bicycle Therapeutics | $24.76 | 162.52% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 09/12/2023 | AFMD | Buy Now | Affimed | $5.29 | 32.33% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | VINC | Buy Now | Vincerx Pharma | $0.63 | 693.65% | → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.20 | 150% | → $3 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | PRTG | Buy Now | Portage Biotech | $0.20 | 5400% | → $11 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | ONCT | Buy Now | Oncternal Therapeutics | $7.00 | -81.43% | → $26 | Reiterates | Neutral → Neutral | Get Alert |
| 09/07/2023 | KURA | Buy Now | Kura Oncology | $20.32 | 47.64% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | FATE | Buy Now | Fate Therapeutics | $5.67 | -11.89% | → $5 | Reiterates | Neutral → Neutral | Get Alert |
| 09/07/2023 | CRVS | Buy Now | Corvus Pharma | $2.65 | 50.94% | → $4 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | BCYC | Buy Now | Bicycle Therapeutics | $24.76 | 162.52% | → $65 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | ASND | Buy Now | Ascendis Pharma | $136.85 | 11.07% | → $152 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | ARVN | Buy Now | Arvinas | $27.30 | 156.41% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | APTO | Buy Now | Aptose Biosciences | $0.55 | 6781.56% | → $38 | Reiterates | Overweight → Overweight | Get Alert |
| 09/07/2023 | AFMD | Buy Now | Affimed | $5.29 | 32.33% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | PRTG | Buy Now | Portage Biotech | $0.20 | 5400% | → $11 | Reiterates | Overweight → Overweight | Get Alert |
| 08/01/2023 | PRTG | Buy Now | Portage Biotech | $0.20 | 5400% | $16 → $11 | Maintains | Overweight | Get Alert |
| 07/21/2023 | KURA | Buy Now | Kura Oncology | $20.32 | 47.64% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 06/13/2023 | KURA | Buy Now | Kura Oncology | $20.32 | 47.64% | → $30 | Reiterates | Overweight → Overweight | Get Alert |
| 06/12/2023 | APTO | Buy Now | Aptose Biosciences | $0.55 | 6781.56% | $6 → $38 | Maintains | Overweight | Get Alert |
| 06/01/2023 | ASND | Buy Now | Ascendis Pharma | $136.85 | 11.07% | → $152 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2023 | CRVS | Buy Now | Corvus Pharma | $2.65 | 50.94% | $2 → $4 | Maintains | Overweight | Get Alert |
| 05/04/2023 | FATE | Buy Now | Fate Therapeutics | $5.67 | -11.89% | $8 → $5 | Maintains | Neutral | Get Alert |
| 04/28/2023 | ASND | Buy Now | Ascendis Pharma | $136.85 | 11.07% | $142 → $152 | Maintains | Overweight | Get Alert |
| 04/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | $7.00 | -81.43% | $80 → $26 | Maintains | Overweight | Get Alert |
| 02/27/2023 | BCYC | Buy Now | Bicycle Therapeutics | $24.76 | 198.87% | → $74 | Reiterates | → Overweight | Get Alert |
| 01/31/2023 | ARVN | Buy Now | Arvinas | $27.30 | 229.67% | → $90 | Reiterates | → Overweight | Get Alert |
| 12/22/2022 | ONCT | Buy Now | Oncternal Therapeutics | $7.00 | -42.86% | → $80 | Initiates | → Overweight | Get Alert |
| 11/04/2022 | FATE | Buy Now | Fate Therapeutics | $5.67 | 692.95% | $98 → $45 | Assumes | → Overweight | Get Alert |
| 08/12/2022 | NKTX | Buy Now | Nkarta | $6.70 | 467.16% | $60 → $38 | Maintains | Overweight | Get Alert |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $75 → $68.5 | Downgrade | Overweight → Neutral | Get Alert |
| 07/12/2022 | KURA | Buy Now | Kura Oncology | $20.32 | 47.64% | → $30 | Initiates | → Overweight | Get Alert |
| 06/28/2022 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.20 | 400% | $10 → $6 | Maintains | Overweight | Get Alert |
| 06/08/2022 | VINC | Buy Now | Vincerx Pharma | $0.63 | 1169.84% | $22 → $8 | Maintains | Overweight | Get Alert |
| 02/23/2022 | AFMD | Buy Now | Affimed | $5.29 | 126.84% | → $120 | Initiates | → Overweight | Get Alert |
| 12/23/2021 | VINC | Buy Now | Vincerx Pharma | $0.63 | 3868.25% | → $25 | Initiates | → Overweight | Get Alert |
